Neurofilament light polypeptide
| GO Term | Evidence Code | Reference |
|---|---|---|
| microtubule cytoskeleton organization |
|
|
| axonogenesis |
|
|
| anterograde axonal transport | ||
| retrograde axonal transport | ||
| response to toxic substance |
| GO Term | Evidence Code | Reference |
|---|---|---|
| structural constituent of cytoskeleton | ||
| structural constituent of cytoskeleton | ||
| tubulin binding | ||
| protein domain specific binding | ||
| protein-macromolecule adaptor activity |
| Position | Description | PubMed ID | GlyTouCan ID | Source |
|---|---|---|---|---|
| 21 |
|
|||
| 27 |
|
|||
| 34 |
|
|||
| 38 |
|
|||
| 41 |
|
|||
| 42 |
|
|||
| 44 |
|
|||
| 48 |
|
|||
| 49 |
|
|||
| 50 |
|
| Pathway Name | Organism |
|---|---|
| Assembly and cell surface presentation of NMDA receptors | Homo sapiens |
| Long-term potentiation | Homo sapiens |
| Negative regulation of NMDA receptor-mediated neuronal transmission | Homo sapiens |
| RAF/MAP kinase cascade | Homo sapiens |
| Ras activation upon Ca2+ influx through NMDA receptor | Homo sapiens |
| Unblocking of NMDA receptors, glutamate binding and activation | Homo sapiens |
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0080294 | Charcot-Marie-Tooth disease dominant intermediate G | |
| DOID:0110149 | Charcot-Marie-Tooth disease type 1F | |
| DOID:0110165 | Charcot-Marie-Tooth disease type 2E | |
| DOID:10595 | Charcot-Marie-Tooth disease | |
| DOID:3008 | invasive ductal carcinoma | |
| DOID:332 | amyotrophic lateral sclerosis |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026